[PDF][PDF] Different metabolic responses of human brown adipose tissue to activation by cold and insulin

…, V Oikonen, T Noponen, T Viljanen, M Scheinin… - Cell metabolism, 2011 - cell.com
We investigated the metabolism of human brown adipose tissue (BAT) in healthy subjects
by determining its cold-induced and insulin-stimulated glucose uptake and blood flow (…

Distribution of α2-adrenergic receptor subtype gene expression in rat brain

M Scheinin, JW Lomasney, DM Hayden-Hixson… - Molecular Brain …, 1994 - Elsevier
α 2 -Adrenergic receptors in brain are important presynaptic modulators of central noradrenergic
function (autoreceptors) and postsynaptic mediators of many of the widespread effects …

Gene targeting—homing in on α2-adrenoceptor-subtype function

E MacDonald, BK Kobilka, M Scheinin - Trends in pharmacological …, 1997 - cell.com
… Ewen MacDonald, Brian Kobilka and Mika Scheinin describe how these mice may be
utilized to elucidate the physiological functions of the receptor subtypes and the properties of …

Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery.

…, J Kanto, M Scheinin, A Kallio, H Scheinin - Anesthesiology, 1990 - europepmc.org
The effects of dexmedetomidine, an alpha 2-adrenoceptor agonist, on vigilance, thiopental
anesthetic requirements, and the hemodynamic, catecholamine, and hormonal responses to …

Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine

P Talke, CA Richardson, M Scheinin… - Anesthesia & …, 1997 - journals.lww.com
Dexmedetomidine is a selective alpha 2-adrenoceptor agonist with centrally mediated
sympatholytic, sedative, and analgesic effects. This study evaluated: 1) pharmacokinetics of …

[HTML][HTML] A randomized trial of a transglutaminase 2 inhibitor for celiac disease

…, Y Zopf, AW Lohse, M Scheinin… - … England Journal of …, 2021 - Mass Medical Soc
Background In celiac disease, small intestinal transglutaminase 2 causes deamidation of
glutamine residues in gluten peptides, which enhances stimulation of T cells and leads to …

Effects of dexmedetomidine, a selective α2‐adrenoceptor agonist, on hemodynamic control mechanisms

A Kallio, M Scheinin, M Koulu… - Clinical …, 1989 - Wiley Online Library
Dexmedetomidine, a selective α 2 ‐adrenoceptor agonist, was administered to five healthy
male volunteers in single intravenous doses of 12.5, 25, 50, and 75 µg as part of a placebo‐…

Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy

…, E Engblom, A Naum, K Någren, M Scheinin… - Circulation, 2008 - Am Heart Assoc
Background— The anti-ischemic agent trimetazidine improves ejection fraction in heart failure
that is hypothetically linked to inhibitory effects on cardiac free fatty acid (FFA) oxidation. …

Bioavailability of dexmedetomidine after intranasal administration

…, T Manner, R Aantaa, M Lahtinen, M Scheinin… - European journal of …, 2011 - Springer
Purpose The aim of this proof-of-concept study was to characterize the pharmacokinetics
and pharmacodynamics of intranasal dexmedetomidine compared with its intravenous …

Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6‐hydroxydopamine and 1‐methyl‐4‐phenyl‐1,2,3,6 …

…, J Kaslin, N Peitsaro, M Scheinin… - Journal of …, 2004 - Wiley Online Library
Dopaminergic deficiency in the brain of zebrafish was produced by systemic administration
of two catecholaminergic neurotoxins, 6‐hydroxydopamine (6‐OHDA) and 1‐methyl‐4‐…